Therapeutic Potential Of Inhaled Roflumilast N-Oxide In Airway Disorders

被引:0
|
作者
Viswanadha, S. [1 ]
Routhu, K. [1 ]
Khapra, P. [2 ]
Raval, A. [2 ]
机构
[1] Incozen Therapeut Pvt Ltd, Hyderabad, Andhra Pradesh, India
[2] Alemb Pharmaceut Ltd, Vadodhara, India
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4248
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide
    von Richter, Oliver
    Lahu, Gezim
    Huennemeyer, Andreas
    Herzog, Rolf
    Zech, Karl
    Hermann, Robert
    CLINICAL PHARMACOKINETICS, 2007, 46 (07) : 613 - 622
  • [2] Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
    Oliver von Richter
    Gezim Lahu
    Andreas Huennemeyer
    Rolf Herzog
    Karl Zech
    Robert Hermann
    Clinical Pharmacokinetics, 2007, 46 : 613 - 622
  • [3] Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide
    Lahu, G.
    Huennemeyer, A.
    Herzog, R.
    McCracken, N.
    Hermann, R.
    Elmlinger, M.
    Zech, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (04) : 236 - 245
  • [4] Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects
    Nassr, Nassr
    Huennemeyer, Andreas
    Herzog, Rolf
    von Richter, Oliver
    Hermann, Robert
    Koch, Manuela
    Duffy, Kevin
    Zech, Karl
    Lahu, Gezim
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (04) : 580 - 587
  • [5] Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
    Lahu, Gezim
    Huennemeyer, Andreas
    von Richter, Oliver
    Hermann, Robert
    Herzog, Rolf
    McCracken, Nigel
    Zech, Karl
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (11): : 1339 - 1349
  • [6] Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells
    Patel, Brijeshkumar S.
    Rahman, Md. Mostafizur
    Baehring, Gina
    Xenaki, Dikaia
    Tang, Francesca Su-May
    Oliver, Brian G.
    Ammit, Alaina J.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2017, 56 (04) : 532 - 538
  • [7] SINGLE AND REPEATED DOSE PHARMACOKINETICS OF ROFLUMILAST AND ROFLUMILAST N-OXIDE IN A HEALTHY CHINESE POPULATION
    Hu, P.
    Liu, H. Z.
    Chen, X.
    Nassr, N.
    Lahu, G.
    Huennemeyer, A.
    RESPIROLOGY, 2012, 17 : 38 - 38
  • [8] Effect of CYP3A4 inhibition by ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide
    Hünnemeyer, A
    Lahu, G
    Duursema, L
    Burger, F
    Potgieter, MA
    Knoerzer, D
    Venter, L
    Zech, K
    Bethke, TD
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 708 - 708
  • [9] Steady-State Pharmacokinetics of Roflumilast and Roflumilast N-Oxide in Patients with Mild and Moderate Liver Cirrhosis
    Robert Hermann
    Nassr Nassr
    Gezim Lahu
    Éva Péterfai
    Dietrich Knoerzer
    Rolf Herzog
    Karl Zech
    Christian de Mey
    Clinical Pharmacokinetics, 2007, 46 : 403 - 416
  • [10] Steady-state pharmacokinetics of roflumilast and roflumilast N-oxide in patients with mild and moderate liver cirrhosis
    Hermann, Robert
    Nassr, Nassr
    Lahu, Gezim
    Peterfai, Eva
    Knoerzer, Dietrich
    Herzog, Rolf
    Zech, Karl
    de Mey, Christian
    CLINICAL PHARMACOKINETICS, 2007, 46 (05) : 403 - 416